Bone and bone derived factors in kidney disease

Bone and bone derived factors in kidney disease

Purpose of review: Mineral and bone disorder (MBD) is a prevalent complication in chronic kidney disease (CKD), significantly impacting overall health with multifaceted implications including fractures, cardiovascular events, and mortality. Despite its pervasive nature, effective treatments for CKD-...

Full description

Bibliographic Details
Main Author:	Petra Simic
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Physiology
Subjects:	renal osteodystrophy CKD-MBD mineral and bone disorder CKD FGF23 = fibroblast growth factor 23
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2024.1356069/full

Similar Items

Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
by: Ariane Zaloszyc, et al.
Published: (2023-03-01)

Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
by: Kanda Eiichiro, et al.
Published: (2012-09-01)

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
by: Matthew J. Damasiewicz, et al.
Published: (2018-11-01)

Bone Disease in Chronic Kidney Disease and Kidney Transplant
by: Ezequiel Bellorin-Font, et al.
Published: (2022-12-01)

Risk factors associated with disturbances of calcium homeostasis after initiation of a phosphate‐restricted diet in cats with chronic kidney disease
by: Pak‐Kan Tang, et al.
Published: (2021-01-01)

Is Adynamic Bone Always a Disease? Lessons from Patients with Chronic Kidney Disease
by: Eman Nagy, et al.
Published: (2022-11-01)

The Importance of Phosphate Control in Chronic Kidney Disease
by: Ken Tsuchiya, et al.
Published: (2021-05-01)

Cardiovascular Risk and Mineral Bone Disorder in Patients with Chronic Kidney Disease
by: Hagen Staude, et al.
Published: (2013-03-01)

Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience
by: Orfeas Liangos, et al.
Published: (2018-08-01)

Renal osteodystrophy: A historical review of its origins and conceptual evolution
by: Garabed Eknoyan, et al.
Published: (2022-12-01)

Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease
by: Yi-Chou Hou, et al.
Published: (2022-07-01)

Editorial: Management of osteoporosis in patients with chronic kidney disease
by: Mohamed Abdalbary, et al.
Published: (2023-01-01)

Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
by: Maria Fusaro, et al.
Published: (2022-04-01)

FGF23: From academic nephrology to personalized patients’ care
by: María Luisa González-Casaus, et al.
Published: (2021-05-01)

A New Disease Concept in the Age of Processed Foods—Phosphorus-Burden Disease; including CKD–MBD Concrete Analysis and the Way to Solution
by: Keizo Nishime, et al.
Published: (2021-08-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2022-12-01)

Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
by: Hisato Shima, et al.
Published: (2018-06-01)

Effects of Aldosterone, Osteoprotegerin and Fibroblast Growth Factor-23 and Some Biochemical Markers in Chronic Kidney Disease Patients (Stage II-IV) among Patients with or without Cardiovascular Events
by: Zeyad A. Ameen, et al.
Published: (2018-12-01)

A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
by: Yinghui Lu, et al.
Published: (2023-04-01)

Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy
by: Irma Machuca-Gayet, et al.
Published: (2020-04-01)

Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease
by: Teodora V. Grigore, et al.
Published: (2023-01-01)

Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease
by: Helen V. Alderson, et al.
Published: (2021-10-01)

Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis
by: Armando Aguilar, et al.
Published: (2023-06-01)

The Increase in FGF23 Induced by Calcium Is Partially Dependent on Vitamin D Signaling
by: Sandra Rayego-Mateos, et al.
Published: (2022-06-01)

Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects
by: Paolo Molinari, et al.
Published: (2022-03-01)

Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
by: Megan L. Noonan, et al.
Published: (2020-06-01)

Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients
by: Ahmed Fayed, et al.
Published: (2018-10-01)

Development of experimental chronic kidney disease and vascular calcification alters diurnal variation of phosphate and its hormonal regulators
by: Bruno A. Svajger, et al.
Published: (2020-11-01)

Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies
by: Daniela F. Cardoso, et al.
Published: (2020-08-01)

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
by: Hirosumi Miyakawa, et al.
Published: (2021-09-01)

Effect of Denosumab on Bone Health, Vascular Calcification, and Health-Related Quality of Life in Hemodialysis Patients with Osteoporosis: A Prospective Observational Study
by: Hyunsook Kim, et al.
Published: (2024-03-01)

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort
by: Vervloet Marc G, et al.
Published: (2012-04-01)

MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD
by: Deborah Mattinzoli, et al.
Published: (2022-11-01)

The Evolving World of Chronic Kidney Disease Mineral Bone Disorder
by: Antonio Bellasi, et al.
Published: (2013-07-01)

Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects
by: Jordi Bover, et al.
Published: (2021-05-01)

Ionized hypercalcemia in cats with azotemic chronic kidney disease (2012‐2018)
by: Dirk Hendrik Nicolaas van denBroek, et al.
Published: (2022-07-01)

Assessment of Inorganic Phosphate Intake by the Measurement of the Phosphate/Urea Nitrogen Ratio in Urine
by: María Victoria Pendón-Ruiz de Mier, et al.
Published: (2021-01-01)

Bone-Derived Extracellular Vesicles: Novel Players of Interorgan Crosstalk
by: Yi Li, et al.
Published: (2019-12-01)

Parathyroid diseases and animal models
by: Yasuo eImanishi, et al.
Published: (2012-06-01)

Bone fragility in patients with chronic kidney disease
by: Martine Cohen-Solal, et al.
Published: (2020-04-01)